N/A
N=76
Home Rehabilitation in Patients After Primary Total Knee Arthroplasty
Osteoarthritis · Rehabilitation
Bottom Line
View on ClinicalTrials.gov: NCT02409719 ↗Enrolled (actual)
76
Serious AEs
1.4%
Results posted
Dec 2019
Primary outcome: Primary: Total WOMAC Score — 51.64285714; 52.47619048; 39.60714286; 40.38095238 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Schedule (Other); Verbal Information and Booklet (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Universidad Autonoma de Nuevo Leon
- Primary completion
- Jan 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Total WOMAC Score |
51.64285714; 52.47619048; 39.60714286; 40.38095238; 29.42857143; 30.85714286 | — |
| SECONDARY Visual Analog Scale (Measure of Pain Intensity) |
8.178571429; 8.285714286; 5.392857143; 5.714285714; 4; 4.261904762 | — |
Summary
The investigators include patients attending the outpatient clinic in the area of Orthopedics and Traumatology of the investigators hospital with a diagnosis of knee osteoarthritis, which treatment requires surgery. Patients will be divided into two groups. In both groups, they will be given verbal, clear and detailed information on the approach to follow, the exercises given in brochures, and in the study group a schedule will be given in order to record rehabilitation exercises in patients after total knee replacement (TKA). Both groups will be assessed before and after surgery, together with outpatient follow-up by, WOMAC, Visual Analogue Scale and OKS (Oxford Knee Score).
Eligibility Criteria
Inclusion Criteria
- Age between 18 and 90 years
- Patients with Knee osteoarthritis (OA) grade 4 ( Kellgren-Lawrence based on radiographic findings)
- Total Knee Arthroplasty (TKA) for primary OA
- Rapid rehabilitation desire
Exclusion Criteria
- Age 90 years
- Patients with Knee osteoarthritis grade 1-2 ( Kellgren-Lawrence based on radiographic findings)
- Patients with asociated Rheumatic syndromes
- Patients with anticoagulant therapy
- Patients with hepatic problems, Diabetes Mellitus, Coagulopathy, hearth conditions, immunodepressed, or infections
- Drugs abuse history
- Physiatric disease
- Pregnant patients
- Patients with hemoglobin values < 11g/dl , platelets < 150,000/ μL
Data sourced from ClinicalTrials.gov (NCT02409719). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.